Action Regencell Bioscience - RGC

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

20,41

( 10,74% )

Prix Achat

20,41

Prix Vente

20,57

Volume échangé

9 986

0,00 Fourchette du Jour 0,00

0,0789 Plage de 52 semaines 83,60

Cap du marché

10,092B

Clôture Veille

18,43

Ouverture

Dernière Transaction

20.41

Dernière heure de transaction

10:04:10

Volume financier

VWAP

Volume moyen (3 m)

917 461

Actions en circulation

494 484 952

Rendement du Dividende

Ratio Cours sur Bénéfices

-2 112,64

Bénéfice par action (BPA)

-0,01

Chiffre d'affairess

Bénéfice net

-4,3M

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration. Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Secteur

Medicinal Chems,botanicl Pds

Industrie

Medicinal Chems,botanicl Pds

Site Web

www.regencellbioscience.com

Siège social

Hong Kong, Hkg

Fondé

Regencell Bioscience Holdings Ltd est coté dans le secteur Medicinal Chems,botanicl Pds de la NASDAQ avec le ticker RGC. Le dernier cours de clôture d'Regencell Bioscience était de US$18,43. Au cours de la dernière année, les actions de Regencell Bioscience ont été négociées dans une fourchette de prix de US$ 0,0789 à US$ 83,60.

Regencell Bioscience compte actuellement 494 484 952 actions en circulation. La capitalisation boursière d'Regencell Bioscience est de US$9,11 milliard. Regencell Bioscience a un ratio cours/bénéfice (ratio PE) de -2112.64.

Flux global

Haussier

Prime nette

21k

Calls / Puts

142,86%

Ach. / Vent.

70,00%

OTM / ITM

112,50%

Sweeps Ratio

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	4.71	30	15.7	30	9.39	6660246	21.06923918	CS
4	3.44649998	20.3171513894	16.96350002	83.6	9.39	2675849	31.31755133	CS
12	19.553672	2283.43251651	0.856328	83.6	0.7028149	917461	29.72683748	CS
26	20.279289	15514.6001484	0.130711	83.6	0.0927338	766744	16.68801515	CS
52	20.316109	21637.9727556	0.093891	83.6	0.0789	449907	13.86417516	CS
156	19.41849	1958.47646519	0.99151	83.6	0.0789	150594	13.75529179	CS
260	20.0944	6367.0468948	0.3156	83.6	0.0789	169930	9.45799514	CS

RGC - Frequently Asked Questions (FAQ)

What is the current Regencell Bioscience share price?

The current share price of Regencell Bioscience is US$ 20,41

How many Regencell Bioscience shares are in issue?

Regencell Bioscience has 494 484 952 shares in issue

What is the market cap of Regencell Bioscience?

The market capitalisation of Regencell Bioscience is USD 9,11B

What is the 1 year trading range for Regencell Bioscience share price?

Regencell Bioscience has traded in the range of US$ 0,0789 to US$ 83,60 during the past year

What is the PE ratio of Regencell Bioscience?

The price to earnings ratio of Regencell Bioscience is -2,11k

What is the reporting currency for Regencell Bioscience?

Regencell Bioscience reports financial results in USD

What is the latest annual profit for Regencell Bioscience?

The latest annual profit of Regencell Bioscience is USD -4,3M

What is the registered address of Regencell Bioscience?

The registered address for Regencell Bioscience is 11/F FIRST COMMERCIAL BUILDING, 33-35 LEIGHTON ROAD, HONG KONG, 999077

What is the Regencell Bioscience website address?

The website address for Regencell Bioscience is www.regencellbioscience.com

Which industry sector does Regencell Bioscience operate in?

Regencell Bioscience operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
AACIUArmada Acquisition Corporation II	US$ 10,17 (0,00%)	0
AACIArmada Acquisition Corporation II	US$ 10,04 (0,00%)	0
AACGATA Creativity Global	US$ 0,8402 (0,00%)	0
AACBUArtius II Acquisition Inc	US$ 10,29 (0,00%)	0
AACBArtius II Acquisition Inc	US$ 10,105 (0,00%)	0
AACIUArmada Acquisition Corporation II	US$ 10,17 (0,00%)	0
AACIArmada Acquisition Corporation II	US$ 10,04 (0,00%)	0
AACGATA Creativity Global	US$ 0,8402 (0,00%)	0
AACBUArtius II Acquisition Inc	US$ 10,29 (0,00%)	0
AACBArtius II Acquisition Inc	US$ 10,105 (0,00%)	0
AACIUArmada Acquisition Corporation II	US$ 10,17 (0,00%)	0
AACIArmada Acquisition Corporation II	US$ 10,04 (0,00%)	0
AACGATA Creativity Global	US$ 0,8402 (0,00%)	0
AACBUArtius II Acquisition Inc	US$ 10,29 (0,00%)	0
AACBArtius II Acquisition Inc	US$ 10,105 (0,00%)	0

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Regencell Bioscience Holdings Ltd (RGC) Cours

Regencell Bioscience Holdings Ltd (RGC)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Regencell Bioscience Holdings Ltd

Flux d'options Regencell Bioscience (RGC)

Flux global

Haussier

Prime nette

21k

Calls / Puts

142,86%

Ach. / Vent.

70,00%

OTM / ITM

112,50%

Sweeps Ratio

0,00%

RGC Dernières nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

RGC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Connectez-vous

Supprimer les publicités